Nuvectis Pharma, Inc. (NVCT)
20.55
-1.37
(-6.25%)
USD |
NASDAQ |
Oct 05, 12:21
Nuvectis Pharma Market Cap : 548.58M for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 585.15M |
| October 01, 2026 | 553.12M |
| September 30, 2026 | 563.79M |
| September 29, 2026 | 548.04M |
| September 28, 2026 | 555.52M |
| September 25, 2026 | 539.77M |
| September 24, 2026 | 577.41M |
| September 23, 2026 | 562.46M |
| September 22, 2026 | 613.98M |
| September 21, 2026 | 586.75M |
| September 18, 2026 | 587.29M |
| September 17, 2026 | 570.73M |
| September 16, 2026 | 583.82M |
| September 15, 2026 | 585.15M |
| September 14, 2026 | 623.32M |
| September 11, 2026 | 640.41M |
| September 10, 2026 | 600.37M |
| September 09, 2026 | 608.11M |
| September 08, 2026 | 640.41M |
| September 04, 2026 | 653.76M |
| September 03, 2026 | 650.55M |
| September 02, 2026 | 638.54M |
| September 01, 2026 | 615.58M |
| August 31, 2026 | 606.77M |
| August 28, 2026 | 633.47M |
| Date | Value |
|---|---|
| August 27, 2026 | 672.44M |
| August 26, 2026 | 667.37M |
| August 25, 2026 | 691.13M |
| August 24, 2026 | 637.20M |
| August 21, 2026 | 628.93M |
| August 20, 2026 | 623.32M |
| August 19, 2026 | 622.79M |
| August 18, 2026 | 558.19M |
| August 17, 2026 | 509.34M |
| August 14, 2026 | 506.13M |
| August 13, 2026 | 513.34M |
| August 12, 2026 | 521.62M |
| August 11, 2026 | 518.15M |
| August 10, 2026 | 503.86M |
| August 07, 2026 | 505.87M |
| August 06, 2026 | 502.66M |
| August 05, 2026 | 510.88M |
| August 04, 2026 | 533.16M |
| August 03, 2026 | 572.95M |
| July 31, 2026 | 570.83M |
| July 30, 2026 | 603.72M |
| July 29, 2026 | 548.81M |
| July 28, 2026 | 525.74M |
| July 27, 2026 | 518.31M |
| July 24, 2026 | 512.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Opus Genetics, Inc. | 369.44M |
| Faeth Therapeutics, Inc. | 703.43M |
| ACADIA Pharmaceuticals, Inc. | 3.386B |
| Alnylam Pharmaceuticals, Inc. | 29.00B |
| Savara, Inc. | 981.81M |
Market Cap Related Metrics
| PEG Ratio | -1.188 |
| Price to Book Value | 60.40 |
| Price | 20.55 |
| Earnings Yield | -6.22% |
| PEGY Ratio | -1.188 |